Evidence map›Paper›PMID 26657964›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Somatic DNA Variation in Brain as a Source of Risk for CNS Diseases.

Glenn A Doyle, Wade H Berrettini

Open access · bronzeAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Glenn A DoyleDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wade H BerrettiniDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · US

Funding

Temporal Lobe Epilepsy and RetrotransposonsR21NS095756 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 2015 to 2016
$447k
Retrotransposons in SchizophreniaR21MH101065 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 2013 to 2014
$440k
Cocaine Addiction and RetrotransposonsR21DA035607 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 2013 to 2014
$412k
NIDA NIH HHS R21DA035607NIMH NIH HHS 1R21MH101065NINDS NIH HHS R21 NS095756-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrainCentral Nervous System DiseasesDNAGenetic VariationHumansMutationRisk FactorsDNA

Identifiers

PMID26657964
PMCPMC4677153
OpenAlexW2193227116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.